Integration of multi-modal measurements identifies critical mechanisms of tuberculosis drug action
William C. JohnsoniD, A. Paul Alivisatos, Trever C. SmithiD, Nhi VaniD, Vijay SoniiD, Joshua B. Wallach, Nicholas A. ClarkiD, Timothy A. Fitzgerald, Joshua J. WhiteleyiD, Shumin TaniD, Artem SokoloviD, Dale Michael AndoiD, Dirk SchnappingeriD, Kyu Young RheeiD, Bree B. AldridgeiD
Abstract
Treatments for tuberculosis remain lengthy, motivating a search for new drugs with novel mechanisms of action. However, it remains challenging to elucidate the direct targets of a drug, and even more so, to determine which disrupted cellular processes lead to bacterial killing. We developed a computational tool, DECIPHAER (DEcoding Cross-modal Information of PHarmacologies via AutoEncodeRs), to select the important correlated transcriptional and morphological responses of Mycobacterium tuberculosis to drug treatments. By finding a reduced feature space from these measurements, DECIPHAER highlighted essential features of Mtb cellular damage such as phosphosugar stress and inhibition of translation and DNA replication. After training, DECIPHAER provides cell-death-relevant insight into single-modal datasets, enabling interrogation of drug treatment responses for which transcriptional data are unavailable. Using morphological data alone with DECIPHAER, we discovered that respiration inhibition by the poly-pharmacological drugs, SQ109 and BM212, can influence cell death more than their effects on the cell wall. This study demonstrates that DECIPHAER can extract the critical shared information from multi-modal measurements to identify cell death-relevant mechanisms of TB drugs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 3.34
- Field percentile
- top 8%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Morphological profiling of tubercule bacilli identifies drug pathways of action
T. C. Smith, K. M. Pullen, … B. Aldridge·bioRxiv·Mar 11, 2020
- Transcriptome signature of cell viability predicts drug response and drug interaction for Tuberculosis
V. Srinivas, R. A. Ruiz, … N. S. Baliga·bioRxiv·Feb 9, 2021
- Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against Tuberculosis
Shuyi Ma, Suraj Jaipalli, … Sriram Chandrasekaran·mBioPeer-reviewed·Nov 11, 2019
- Deconvoluting drug interactions based on M. tuberculosis physiologic processes:Transcriptional disaggregation of the BPaL regimen in vivo
Elizabeth A. Wynn, Christian Dide-Agossou, … Nicholas D. Walter·bioRxiv·Feb 24, 2025
- Designing Novel and Potent Inhibitors for Multi Drug-Resistant Tuberculosis: A Computational Approach
Muhammad Idrees, Bashir Ahmad, … Aishma Khattak·Pakistan Journal of ZoologyPeer-reviewed·Aug 24, 2021
- An activator of a two-component system controls cell separation and intrinsic drug resistance in Mycobacterium tuberculosis
Liam D. McDonough, Shuqi Li, … E. Hesper Rego·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 16, 2026